Determining the Prevalence of HIV-Related Neurological Disorders in the Asia Pacific
NCT00168246 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2007-02-27
Summary
This study will determine the prevalence of HIV-related neurological disorders in the countries of the Asia-Pacific Region.
Conditions
- HIV Infections
- HIV Related Neurological Diseases
Sponsors & Collaborators
-
The Alfred
collaborator OTHER -
National Institute of Neurological Disorders and Stroke (NINDS)
collaborator NIH -
National Institute of Mental Health (NIMH)
lead NIH
Principal Investigators
-
Edwina Wright, Dr · The Alfred
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-06-30
Countries
- Australia
Study Locations
More Related Trials
-
Prevalence of HIV-associated Neurocognitive Disorders (HAND) in a School of Medicine HIV/AIDS Outpatient Clinic
NCT02187796 ·Status: COMPLETED
-
HealthMap: an Interactive Health Plan Randomised Trial to Prevent Cardiovascular Disease in People With HIV
NCT02178930 ·Status: COMPLETED ·Phase: NA
-
Thinking and Memory Problems in People With HIV
NCT01875588 ·Status: RECRUITING
-
Impact of HIV-infection on Clinical Characteristics and Outcomes on Stroke in Uganda
NCT03072212 ·Status: COMPLETED
-
HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV Drugs
NCT00001103 ·Status: COMPLETED
-
Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of 55 and 70 Years: An Exposed/Unexposed Cross Sectional Study
NCT02592174 ·Status: COMPLETED ·Phase: NA
-
Functional Imaging Reserve in NeuroHIV
NCT03596268 ·Status: COMPLETED
-
Neurodevelopmental and Neurological Study of Infants and Children With HIV-1 Infection and AIDS in Clinical Trials
NCT00000759 ·Status: COMPLETED
-
An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts
NCT00000709 ·Status: COMPLETED ·Phase: PHASE3
-
Brain Imaging for HIV-Associated Thinking and Mood Disorders
NCT01692236 ·Status: TERMINATED
-
Individualized Cognitive Training in HIV
NCT03122288 ·Status: COMPLETED ·Phase: NA
-
Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population
NCT00796146 ·Status: RECRUITING
-
Identification and Quantification of HIV CNS Latency Biomarkers
NCT02989285 ·Status: UNKNOWN
-
Subclinical Atherosclerosis in HIV-infected Patients
NCT00455793 ·Status: COMPLETED
-
Observational Study of HIV-associated Neurocognitive Disorder
NCT01966094 ·Status: COMPLETED
-
A Study of Decreased Mental Function Associated With HIV
NCT00027040 ·Status: COMPLETED ·Phase: NA
-
Impact of HIV and Its Treatment on Reverse Cholesterol Transport
NCT00168233 ·Status: COMPLETED
-
Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China
NCT01340950 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of Attentional Functioning in Children With HIV-1 Infection
NCT00001497 ·Status: COMPLETED
-
SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy
NCT05586581 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Mental Ability Challenge Study in Adults With and Without HIV
NCT03244488 ·Status: COMPLETED
-
Spirituality and Will to Live in Patients With HIV/AIDS
NCT00122902 ·Status: COMPLETED
-
Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders
NCT01665846 ·Status: COMPLETED ·Phase: PHASE1
-
Central Nervous System Disease in HIV-infected Children on HAART
NCT00110331 ·Status: COMPLETED
-
Teleneuropsychological Intervention in Asymptomatic HIV Seropositive Patients: N&C NeuroChange
NCT05571761 ·Status: WITHDRAWN ·Phase: NA